Anuh Pharma Ltd

Legal & Regulatory

Anuh Pharma Legal & Regulatory

Anuh Pharma disclosed a Rs. 9,93,206 tax demand under Section 156, Income Tax Act, for AY 2018-19. The company plans to appeal before the CIT.

Value

₹0.10 Cr

Earnings Call

Anuh Pharma Investor Presentation: Key Takeaways

Anuh Pharma reported strong Q1 FY27 results with 4% YoY revenue growth and 38% PAT growth, driven by a shift to high-value regulated markets.

Call

Guides 18% growth

Financial Results

Anuh Pharma Q1 FY27 Results: Net Profit ₹11.4 Cr, Up 37.3% YoY

Anuh Pharma Ltd reported revenue from operations of ₹193.8 Cr (+3.9% YoY) and net profit of ₹11.4 Cr (+37.3% YoY) for Q1 FY27.

Key figure

Net profit ₹11.4 Cr · +37.3% YoY

Earnings Call

Anuh Pharma Earnings Call: Key Takeaways

Anuh Pharma reported FY26 revenue growth of 15.66% YoY to ₹776 Cr, driven by strong volumes in regulated markets and successful USFDA/EU GMP inspections.

Financial Results

Anuh Pharma Q4 FY26 Results: Net Profit ₹11.7 Cr, Down 6.4% YoY

Anuh Pharma Ltd reported revenue from operations of ₹202.1 Cr (+2.0% YoY) and net profit of ₹11.7 Cr (-6.4% YoY) for Q4 FY26.

Key figure

Net profit ₹11.7 Cr · -6.4% YoY